QGEN
Qiagen NV
Price:  
40.71 
USD
Volume:  
1,732,469.00
Netherlands | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

QGEN EV/EBITDA

-18.3%
Upside

As of 2025-04-21, the EV/EBITDA ratio of Qiagen NV (QGEN) is 13.72. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. QGEN's latest enterprise value is 9,526.24 mil USD. QGEN's TTM EBITDA according to its financial statements is 694.17 mil USD. Dividing these 2 quantities gives us the above QGEN EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 13.4x - 16.0x 14.2x
Forward P/E multiples 17.0x - 19.3x 17.8x
Fair Price 23.02 - 48.09 33.26
Upside -43.4% - 18.1% -18.3%
40.71 USD
Stock Price
33.26 USD
Fair Price

QGEN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-04-17 13.72
2025-04-16 13.95
2025-04-15 13.98
2025-04-14 14.22
2025-04-11 14.12
2025-04-10 13.52
2025-04-09 13.95
2025-04-08 13.13
2025-04-07 13.60
2025-04-04 12.96
2025-04-03 13.62
2025-04-02 13.51
2025-04-01 13.35
2025-03-31 13.55
2025-03-28 13.46
2025-03-27 13.39
2025-03-26 13.37
2025-03-25 13.40
2025-03-24 13.44
2025-03-21 13.40
2025-03-20 13.30
2025-03-19 13.39
2025-03-18 13.42
2025-03-17 13.45
2025-03-14 13.34
2025-03-13 13.16
2025-03-12 13.32
2025-03-11 13.27
2025-03-10 13.16
2025-03-07 13.42
2025-03-06 13.46
2025-03-05 13.05
2025-03-04 12.82
2025-03-03 12.95
2025-02-28 13.00
2025-02-27 13.00
2025-02-26 13.24
2025-02-25 13.41
2025-02-24 13.47
2025-02-21 13.37
2025-02-20 13.06
2025-02-19 13.26
2025-02-18 13.51
2025-02-14 13.46
2025-02-13 13.52
2025-02-12 13.55
2025-02-11 13.28
2025-02-10 13.53
2025-02-07 13.92
2025-02-06 14.26